Argus initiates coverage on Chemours (NYSE: CC) with a Hold rating.Analyst commented, "In our view, the company has significant competitive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE